The Latest Cancer Drugs News

The Latest Cancer Drugs News
With a survival rate of only five years, the most common and aggressive form of…
Bleomycin is a drug used to treat certain cancers, such as Hodgkin lymphoma and germ…
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…
On February 5, 2021, the Food and Drug Administration granted accelerated approval to umbralisib, a…
Researchers from Houston Methodist, USA, have developed a mathematical model to predict how specific cancers…
The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo…
ProAgio, a drug developed by Georgia State University (USA) biology professor Zhi-Ren Liu and his…
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may…
UNSW scientists have grown human pancreatic cancer tumours in the lab—their model is the first…
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…